Triple-negative breast cancer: Neoadjuvant durvalumab improves prognosis

被引：0
|
作者：
Kunzell, Judith Lorenz
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
D O I：
10.1055/a-1985-2104
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Eine vielversprechende Therapiestrategie beim fruhen Mammakarzinom ist die Gabe von Immuncheckpoint-Inhibitoren zusatzlich zur neoadjuvanten Chemotherapie. Die GeparNuevo-Studie prufte bei Frauen mit einem triple-negativen Tumor den PD-L1-(Programmed Death-Ligand 1-)Inhibitor Durvalumab zusatzlich zur anthrazyklin-/taxanbasierten Zytostase gegen Placebo. Nun liegen die Ergebnisse zu den sekundaren uberlebensendpunkten vor.
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ctDNA prognosis in adjuvant triple-negative breast cancer
    Molinero, Luciana
    Renner, Derrick
    Wu, Hsin-Ta
    Qi, Nina
    Patel, Rajesh
    Chang, Ching-Wei
    Sethi, Himanshu
    Aleshin, Alexey
    Bais, Carlos
    Cameron, David
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Clinical features and prognosis of triple-negative breast cancer
    M Izquierdo Sanz
    A Alsina Maqueda
    M Cabero Riera
    R Fabregas Xaurado
    F Tresserra Casas
    M Cusido Gimferrer
    C Ara Perez
    A Úbeda Hernandez
    Breast Cancer Research, 11
  • [23] Triple-negative breast cancer in the elderly: Prognosis and treatment
    Kaplan, Henry G.
    Malmgren, Judith A.
    Atwood, Mary K.
    BREAST JOURNAL, 2017, 23 (06): : 630 - 637
  • [24] UPDATE ON TRIPLE-NEGATIVE BREAST CANCER: THE GOOD PROGNOSIS
    Sakhri, S.
    Hamza, K.
    Kamoun, S.
    Houcine, Y.
    Karima, T.
    Bouhani, M.
    Bettaib, I.
    Driss, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A306 - A306
  • [25] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Paul Gass
    Michael P. Lux
    Claudia Rauh
    Alexander Hein
    Mayada R. Bani
    Cornelia Fiessler
    Arndt Hartmann
    Lothar Häberle
    Jutta Pretscher
    Ramona Erber
    David L. Wachter
    Rüdiger Schulz-Wendtland
    Matthias W. Beckmann
    Peter A. Fasching
    Marius Wunderle
    BMC Cancer, 18
  • [26] TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer
    Wang, Kaijing
    Chai, Jia
    Xu, Junpeng
    Wei, Jie
    Li, Peifeng
    Liu, Yixiong
    Ma, Jing
    Xu, Tianqi
    Zhao, Danhui
    Yu, Kangjie
    Fan, Linni
    Yan, Qingguo
    Guo, Shuangping
    Li, Mingyang
    Wang, Zhe
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 226
  • [27] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Gass, Paul
    Lux, Michael P.
    Rauh, Claudia
    Hein, Alexander
    Bani, Mayada R.
    Fiessler, Cornelia
    Hartmann, Arndt
    Haeberle, Lothar
    Pretscher, Jutta
    Erber, Ramona
    Wachter, David L.
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    Wunderle, Marius
    BMC CANCER, 2018, 18
  • [28] Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer
    Moore-Smith, Lakisha
    Forero-Torres, Andres
    Stringer-Reasor, Erica
    SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (04) : 773 - +
  • [29] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
  • [30] Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
    Denkert, Carsten
    Schneeweiss, Andreas
    Rey, Julia
    Karn, Thomas
    Hattesohl, Akira
    Weber, Karsten E.
    Rachakonda, Sivaramakrishna
    Braun, Michael
    Huober, Jens
    Jank, Paul
    Sinn, Hans-Peter
    Zahm, Dirk-Michael
    Felder, Barbel
    Hanusch, Claus
    Teply-Szymanski, Julia
    Marme, Frederik
    Fehm, Tanja
    Thomalla, Jorg
    V. Sinn, Bruno
    Stiewe, Thorsten
    Marczyk, Michal
    Blohmer, Jens-Uwe
    van Mackelenbergh, Marion
    Schem, Christian
    Staib, Peter
    Link, Theresa
    Muller, Volkmar
    Stickeler, Elmar
    Stover, Daniel G.
    Solbach, Christine
    Metzger-Filho, Otto
    Jackisch, Christian
    Geyer Jr, Charles E.
    Fasching, Peter A.
    Pusztai, Lajos
    Nekljudova, Valentina
    Untch, Michael
    Loibl, Sibylle
    CELL REPORTS MEDICINE, 2024, 5 (11)
12345